CKD Bio (063160.KS) Stock Price
CKD Bio Price
Revenue has compounded at 4.3% per year over the past 19 years to 160.07 B KRW. Earnings per share have grown at 18.0% per year over the last 18 years. CKD Bio's net margin stands at -1.8%, up from -4.6% several years earlier. CKD Bio currently offers a dividend yield of about 0.72%. The payout ratio is around 6% of earnings. Analysts set a median price target of 40,362.86 KRW, implying 192.5% above the current price. Of 7 analysts, 6 rate the stock a buy — an overall Buy consensus.
CKD Bio stock price
CKD Bio business model & stock analysis
Frequently asked questions about CKD Bio
Analysts currently set an average price target of 40,362.86 KRW for the CKD Bio stock (median: 40,362.86 KRW), implying +192.5 % versus the latest price. The consensus is based on 7 analyst ratings.
5 analysts currently rate the CKD Bio stock: 4 recommend buying, 1 holding and 0 selling.
Converted at the current exchange rate, the CKD Bio share trades at 9.18 EUR (13,800.00 KRW).
The revenue cannot currently be calculated for CKD Bio.
The profit cannot currently be calculated for CKD Bio.
The P/E ratio cannot be calculated for CKD Bio at the moment.
The P/S cannot be calculated for CKD Bio currently.
The Eulerpool Quality Score for CKD Bio is 3/10.
The ISIN of CKD Bio is KR7063160006. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of CKD Bio is 063160.KS. The ticker symbol is used to trade CKD Bio shares on the stock exchange.
CKD Bio stock
CKD Bio Peer Group
CKD Bio FIGI
All fundamentals and in-depth analysis of CKD Bio
Our stock analysis for CKD Bio stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of CKD Bio. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.